SCHEMBL457223

SCHEMBL457223

Cc1ccnc(C=O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29875378 1.00 — —
Diethylamine SCHEMBL6640415 0.89 UHRF1 (0.41) —
SCHEMBL20412648 0.79 CCR1 (0.59) —
SCHEMBL1707282 0.79 — —
SCHEMBL25244672 0.78 FDPS (0.44) —
SCHEMBL30479916 0.78 FDPS (0.44) —
SCHEMBL3077708 0.77 — —
SCHEMBL1282140 0.77 — —
SCHEMBL7609085 0.76 ERN1 (0.38) —
SCHEMBL25375499 0.76 KDM4A (0.51) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119977951-A DASAs molecular optical switch capable of realizing solid film isomerization and synthesis method and application thereof 南京理工大学 2025-05-13 — — CN claimed
WO-2021013419-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL HENKEL AG & CO. KGAA (DE) 2021-01-28 — — WO claimed
CN-110423234-B Thiosemicarbazone derivative containing indole fragment and preparation method and application thereof 郑州大学 2020-06-30 — — CN claimed
CN-109134356-A A kind of preparation method of intermediate 2-amino pyridine -4- methanol 苏州盖德精细材料有限公司 2019-01-04 — — CN claimed
EP-1581525-A2 COMPOUNDS HAVING AN ACTIVITY AT METABOTROPIC GLUTAMATE RECEPTORS AstraZeneca AB (SE) 2005-10-05 — — EP claimed
US-20040106607-A1 New compounds ASTRAZENECA AB AND NPS PHARMACEUTICALS, INC. 2004-06-03 — — US claimed
WO-2004014902-A2 COMPOUNDS HAVING AN ACTIVITY AT METABOTROPIC GLUTAMATE RECEPTORS ASTRAZENECA AB (SE) 2004-02-19 — — WO claimed
EP-1065206-B1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents PFIZER (US) 2002-10-09 — — EP claimed
EP-0618222-A2 Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid CIBA-GEIGY AG (CH) 1994-10-05 — — EP claimed
US-12582645-B2 Chemokine CXCR4 receptor modulators and uses related thereto EMORY UNIVERSITY (US) 2026-03-24 — — US disclosed
CN-119977951-B DASAs molecular optical switch capable of realizing solid film isomerization and synthesis method and application thereof 南京理工大学 2025-12-19 — — CN disclosed
US-20250353844-A1 TETRAHYDROPYRIDO 3,4-D PYRIMIDINE DERIVATIVES AS KRAS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2025-11-20 — — US disclosed
EP-4463452-B1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC (US) 2025-07-30 — — EP disclosed
US-12344600-B2 c-Myc mRNA translation modulators and uses thereof in the treatment of cancer ANIMA BIOTECH INC. (US) 2025-07-01 — — US disclosed
EP-0039863-A1 1,4-Dihydropyridines with different substituents in positions 2 and 6, processes for their preparation and their use in medicines BAYER AG (DE) 1981-11-18 — — EP disclosed
US-4248873-A Nitro-substituted 1,4-dihydropyridines, processes for _their production and their medicinal use BAYER AKTIENGESELLSCHAFT (DE) 1981-02-03 — — US disclosed
EP-0012180-A1 1,4-Dihydropyridine compounds, their preparation, pharmaceutical compositions containing said compounds and preparation of these compositions BAYER AG (DE) 1980-06-25 — — EP disclosed
US-4179500-A 1,4-Dihydropyridine-sugar derivatives, and their use as medicaments BAYER AKTIENGESELLSCHAFT (DE) 1979-12-18 — — US disclosed
EP-0002208-A1 Nitro 1,4-dihydropyridines, medicaments containing them and their manufacture BAYER AG (DE) 1979-06-13 — — EP disclosed
EP-0001769-A1 Sulfur-containing esters of 1,4-dihydropyridine carboxylic acids, their preparation and pharmaceutical use BAYER AG (DE) 1979-05-16 — — EP disclosed
Send feedback